Jani van Loghem, MD, PhD

Professional Summary
A pioneering leader in the field of Aesthetic Medicine, Dr. Jani van Loghem specializes in minimally invasive aesthetic treatments, particularly facial filler and biostimulatory product procedures. With a PhD focused on optimizing safety in facial filler treatments, Dr. van Loghem has played a critical role in the evolution of Aesthetic Medicine as a recognized medical profile specialty in the Netherlands. As the founder of UMA Institute, he has established a premier educational center, UMA Academy, that trains hundreds of doctors worldwide annually. Currently, he serves as an Assistant Professor at the University of Amsterdam, mentoring PhD candidates in aesthetic medicine and regenerative aesthetics research.
Jani: "I see the field of Aesthetic Medicine as a true medical specialty. Aesthetic Medicine is a fast growing and exciting field and I’m proud to be part of its development."
Dr. Arthur Swift: “When I decided to build a program dedicated to regenerative aesthetics, Dr. Jani van Loghem was my immediate choice as invited faculty. Few physicians have done more to advance the science and clinical application of biostimulators, particularly CaHA and PLLA. His research, teaching, and clinical innovation have helped define many of the treatment principles and protocols used by practitioners worldwide, and his textbook, Calcium Hydroxylapatite Soft Tissue Fillers: Expert Treatment Techniques, has become the definitive reference for aesthetic injectors.”
Financial relationships
-
Type of financial relationship:ConsultantIneligible company:VivacyTopic:Regenerative aesthetics, Biostimulators and HA fillersDate added:09/09/2026Date updated:09/09/2026
-
Type of financial relationship:ConsultantIneligible company:merz aestheticsTopic:Regenerative aesthetics, Biostimulators and HA fillers and toxinDate added:09/09/2026Date updated:09/09/2026
-
Type of financial relationship:ConsultantIneligible company:GaldermaTopic:Regenerative aesthetics, Biostimulators and HA fillers and toxinDate added:09/09/2026Date updated:09/09/2026
-
Type of financial relationship:ConsultantIneligible company:Nordberg MedicalTopic:Regenerative aesthetics, Biostimulators and HA fillersDate added:09/09/2026Date updated:09/09/2026
-
Type of financial relationship:ConsultantIneligible company:Joonghun PharmaceuticalsTopic:Regenerative aesthetics, Biostimulators and HA fillersDate added:09/09/2026Date updated:09/09/2026
-
Type of financial relationship:ConsultantIneligible company:PharmaResearchTopic:Regenerative aestheticsDate added:09/09/2026Date updated:09/09/2026
-
Type of financial relationship:ConsultantIneligible company:BioscienceTopic:Regenerative aesthetics, Biostimulators and HA fillersDate added:09/09/2026Date updated:09/09/2026

Facebook
X
LinkedIn
Forward